Published in Gastroenterology on May 14, 2015
Epidemiology of Diabetes Interventions and Complications (EDIC) | NCT00360893
Diabetes Control and Complications Trial (DCCT) | NCT00360815
Relationship Between Control of Glycemia and Gastric Emptying Disturbances in Diabetes Mellitus. Clin Gastroenterol Hepatol (2015) 0.83
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy. Diabetologia (2017) 0.81
Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis. Neurogastroenterol Motil (2016) 0.76
The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients. J Neurogastroenterol Motil (2016) 0.75
Diabetes and the Stomach. Curr Treat Options Gastroenterol (2017) 0.75
Changes in expression of inhibitory substances in the intramural neurons of the stomach following streptozotocin- induced diabetes in the pig. World J Gastroenterol (2017) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Functional bowel disorders. Gastroenterology (2006) 20.72
The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes (1995) 8.89
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care (1999) 8.33
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA (2002) 6.61
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol (2008) 3.83
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med (1958) 2.46
Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med (1983) 2.40
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes. Clin Gastroenterol Hepatol (2014) 2.02
Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98
Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.95
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93
Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes (2014) 1.81
Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology (1997) 1.77
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol (1989) 1.74
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut (2008) 1.67
Prevalence of abnormal gastric emptying in asymptomatic women with newly detected diabetes and its reversibility after glycemic control-a prospective case control study. J Diabetes Complications (2012) 1.55
GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol (2002) 1.53
Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci (2012) 1.49
Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut (2012) 1.49
Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol (2010) 1.46
Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.42
Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes (2005) 1.34
Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology (2009) 1.33
Clinical applications of 13CO2 measurements. Fed Proc (1982) 1.30
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res (2004) 1.26
Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol (2011) 1.26
A 25-year longitudinal evaluation of gastric emptying in diabetes. Diabetes Care (2012) 1.22
Autonomic dysfunction in gastrointestinal motility disorders. Gut (1993) 1.18
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil (2012) 1.07
A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol (2008) 1.05
Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther (2009) 1.00
Functional dyspepsia and gastroparesis: one disease or two? Am J Gastroenterol (2012) 0.95
Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther (2006) 0.95
The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol (2009) 0.94
The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol (2013) 0.91
Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil (2012) 0.87
Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc (1993) 0.78
Obstructive sleep apnea is a risk factor for Barrett's esophagus. Clin Gastroenterol Hepatol (2013) 2.11
A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis. Clin Gastroenterol Hepatol (2014) 0.84
Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2015) 0.80
Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2014) 0.80
Relationship Among Anal Sphincter Injury, Patulous Anal Canal, and Anal Pressures in Patients With Anorectal Disorders. Clin Gastroenterol Hepatol (2015) 0.79
Lower Prevalence of Celiac Disease and Gluten-Related Disorders in Persons Living in Southern vs Northern Latitudes of the United States. Gastroenterology (2017) 0.77
Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease. Clin Gastroenterol Hepatol (2016) 0.75
Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression. Clin Gastroenterol Hepatol (2016) 0.75
The US Preventive Services Task Force Recommendation on Screening for Asymptomatic Celiac Disease: A Dearth of Evidence. JAMA (2017) 0.75
Relationship between symptoms during a gastric emptying study and intestinal chemosensitivity with daily symptoms. Neurogastroenterol Motil (2019) 0.75
Reply. Gastroenterology (2017) 0.75